FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134750318> ?p ?o ?g. }

• W3134750318 endingPage "285" @default.
• W3134750318 startingPage "278" @default.
• W3134750318 abstract "Literature on treating acquired dermal macular hyperpigmentation is sparse.To assess treatment response of mycophenolate mofetil in patients having acquired dermal macular hyperpigmentation.In this open-label, pilot study, patients of acquired dermal macular hyperpigmentation affecting at least the face and/or neck were included. Each participant was treated with mycophenolate mofetil 2 g/day for 24 weeks, with a follow-up of 12 weeks. Two aspects of disease severity were measured: activity (appearance of new lesions/extension of existing lesions), and degree of hyperpigmentation (measured using 'dermal pigmentation area and severity index'). Patient satisfaction was assessed on a scale of 0-10.Forty-three of 46 patients who were prescribed mycophenolate, completed the study (40 females, 6 males; mean disease duration 2.8 ± 1.4 years). Amongst 20 (43.5%) patients with active disease, stability was achieved in 17, after a mean duration of 6.1 ± 2.5 weeks (range 4-12 weeks; median 4; IQR 4 weeks). Mean dermal pigmentation area and severity index at baseline was 18.8 ± 7.1 and decreased to 13.7 ± 6.3 at 24th week (27.5 ± 14.7%; P < 0.001). A significant decreasing trend in dermal pigmentation area and severity index (P < 0.001) was observed, and first significant difference from baseline was noted at the 16th week (P 0.008). Less than 10%, >10-20%, >20%-30%, >30%-40%, >40%-50%, and >50% reduction in dermal pigmentation area and severity index was observed in 8, 5, 4, 15, 10 and 1 patients/patient respectively. The maximum mean grade of pre-treatment dermatoscopic severity was 3 ± 0.7, and decreased to 2.1 ± 0.8 on the face (P < 0.001) and 2.4 ± 0.7 on the neck (P < 0.001) post-treatment. There were 9 (20.1%) non-responders. Self-assessment scores of the rest of the patients fell in the range of moderate/fair improvement (>5 to 7). No significant correlation was seen between patient satisfaction score and degree of reduction in dermal pigmentation area and severity index (r -0.39). Three developed adverse effects (leucopenia, n = 1; transaminitis and hyperbilirubinemia, n = 2) that resolved following discontinuation of mycophenolate.Mycophenolate mofetil appears to be a promising treatment option in acquired dermal macular hyperpigmentation." @default.
• W3134750318 created "2021-03-15" @default.
• W3134750318 creator A5002759714 @default.
• W3134750318 creator A5007017268 @default.
• W3134750318 creator A5032877306 @default.
• W3134750318 creator A5056862086 @default.
• W3134750318 creator A5079654179 @default.
• W3134750318 creator A5086676176 @default.
• W3134750318 date "2021-03-04" @default.
• W3134750318 modified "2023-10-05" @default.
• W3134750318 title "Oral mycophenolate mofetil in the treatment of acquired dermal macular hyperpigmentation: An open‐label pilot study" @default.
• W3134750318 cites W1990487014 @default.
• W3134750318 cites W2006239446 @default.
• W3134750318 cites W2015296278 @default.
• W3134750318 cites W2035255371 @default.
• W3134750318 cites W2038929265 @default.
• W3134750318 cites W2042109784 @default.
• W3134750318 cites W2045528417 @default.
• W3134750318 cites W2086572550 @default.
• W3134750318 cites W2115499731 @default.
• W3134750318 cites W2115632765 @default.
• W3134750318 cites W2115660235 @default.
• W3134750318 cites W2115692269 @default.
• W3134750318 cites W2117278013 @default.
• W3134750318 cites W2133893960 @default.
• W3134750318 cites W2328026924 @default.
• W3134750318 cites W2602388891 @default.
• W3134750318 cites W2763410463 @default.
• W3134750318 cites W2778933703 @default.
• W3134750318 cites W2891970215 @default.
• W3134750318 cites W2916732456 @default.
• W3134750318 cites W2923766774 @default.
• W3134750318 doi "https://doi.org/10.1111/ajd.13567" @default.
• W3134750318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33660856" @default.
• W3134750318 hasPublicationYear "2021" @default.
• W3134750318 type Work @default.
• W3134750318 sameAs 3134750318 @default.
• W3134750318 citedByCount "3" @default.
• W3134750318 countsByYear W31347503182022 @default.
• W3134750318 countsByYear W31347503182023 @default.
• W3134750318 crossrefType "journal-article" @default.
• W3134750318 hasAuthorship W3134750318A5002759714 @default.
• W3134750318 hasAuthorship W3134750318A5007017268 @default.
• W3134750318 hasAuthorship W3134750318A5032877306 @default.
• W3134750318 hasAuthorship W3134750318A5056862086 @default.
• W3134750318 hasAuthorship W3134750318A5079654179 @default.
• W3134750318 hasAuthorship W3134750318A5086676176 @default.
• W3134750318 hasConcept C141071460 @default.
• W3134750318 hasConcept C16005928 @default.
• W3134750318 hasConcept C2776728111 @default.
• W3134750318 hasConcept C2909381827 @default.
• W3134750318 hasConcept C71924100 @default.
• W3134750318 hasConceptScore W3134750318C141071460 @default.
• W3134750318 hasConceptScore W3134750318C16005928 @default.
• W3134750318 hasConceptScore W3134750318C2776728111 @default.
• W3134750318 hasConceptScore W3134750318C2909381827 @default.
• W3134750318 hasConceptScore W3134750318C71924100 @default.
• W3134750318 hasIssue "3" @default.
• W3134750318 hasLocation W31347503181 @default.
• W3134750318 hasLocation W31347503182 @default.
• W3134750318 hasOpenAccess W3134750318 @default.
• W3134750318 hasPrimaryLocation W31347503181 @default.
• W3134750318 hasRelatedWork W197355757 @default.
• W3134750318 hasRelatedWork W2001670512 @default.
• W3134750318 hasRelatedWork W2002828208 @default.
• W3134750318 hasRelatedWork W2072296607 @default.
• W3134750318 hasRelatedWork W2073178330 @default.
• W3134750318 hasRelatedWork W3018679789 @default.
• W3134750318 hasRelatedWork W3158363443 @default.
• W3134750318 hasRelatedWork W3161361340 @default.
• W3134750318 hasRelatedWork W64857424 @default.
• W3134750318 hasRelatedWork W2553530265 @default.
• W3134750318 hasVolume "62" @default.
• W3134750318 isParatext "false" @default.
• W3134750318 isRetracted "false" @default.
• W3134750318 magId "3134750318" @default.
• W3134750318 workType "article" @default.